Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis-Reference-Cited by-同舟云学术

Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis

Published:2021-03-04 Issue:6 Volume:15 Page:711-722
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Jairath Vipul¹,Chan Keith²,Lasch Karen³,Keeping Sam²,Agboton Christian⁴,Blake Aimee⁵,Patel Haridarshan⁶

Affiliation:

1. Western University Schulich School of Medicine and Dentistry, London, ON, Canada

2. Precision HEOR, Vancouver, BC, Canada

3. Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA

4. Takeda Pharmaceuticals International AG, Zurich, Switzerland

5. Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA

6. Immensity Consulting, Inc., Chicago, Illinois, USA

Funder

Takeda Pharmaceuticals U.S.A., Inc

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1880319

Reference63 articles.

1. Ulcerative colitis

2. Systematic review: the costs of ulcerative colitis in Western countries

3. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis

4. The Impact of Ulcerative Colitis on Patients’ Lives Compared to Other Chronic Diseases: A Patient Survey

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study;Biomedicines;2024-09-02

2. Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy;PharmacoEconomics - Open;2024-06-11

3. Association between the COVID-19 pandemic and mental health in very old people in Sweden;PLOS ONE;2024-04-02

4. A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease;American Journal of Gastroenterology;2023-08-24

5. Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-05